Literature DB >> 10718628

Effect of regulated expression of the fragile histidine triad gene on cell cycle and proliferation.

Z Guo1, J K Vishwanatha.   

Abstract

The mechanism of tumor suppressor action of the fragile histidine triad (FHIT) gene is unknown. Disruption of cell cycle regulation leads to the tumor formation and many tumor suppressor genes suppress tumorigenesis through their effect on cell cycle regulation. We examined the expression of FHIT during the cell cycle, and determined whether overexpression of FHIT affects cell cycle kinetics and apoptosis. The FHIT cDNA was cloned into the ecdysone-inducible expression vector in both the sense and antisense orientations. Overexpression of the sense or antisense construct did not affect cell proliferation, cell cycle distribution or apoptosis in human 293T cells. Analysis of the FHIT expression in 293T cells collected at various cell cycle phases showed that the expression of FHIT is not under cell cycle regulation. These results indicate that the tumor suppressor activity of the FHIT gene may be independent of an effect on the cell cycle and apoptosis mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718628     DOI: 10.1023/a:1007068823848

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Kinetic properties and regulation of biliverdin reductase.

Authors:  J E Bell; M D Maines
Journal:  Arch Biochem Biophys       Date:  1988-05-15       Impact factor: 4.013

Review 2.  An FHIT tumor suppressor gene?

Authors:  M M Le Beau; H Drabkin; T W Glover; R Gemmill; F V Rassool; T W McKeithan; D I Smith
Journal:  Genes Chromosomes Cancer       Date:  1998-04       Impact factor: 5.006

Review 3.  Cell cycle regulation and apoptosis.

Authors:  K L King; J A Cidlowski
Journal:  Annu Rev Physiol       Date:  1998       Impact factor: 19.318

4.  Structure and expression of the human FHIT gene in normal and tumor cells.

Authors:  T Druck; P Hadaczek; T B Fu; M Ohta; Z Siprashvili; R Baffa; M Negrini; K Kastury; M L Veronese; D Rosen; J Rothstein; P McCue; M G Cotticelli; H Inoue; C M Croce; K Huebner
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

Review 5.  Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules?

Authors:  L L Kisselev; J Justesen; A D Wolfson; L Y Frolova
Journal:  FEBS Lett       Date:  1998-05-08       Impact factor: 4.124

6.  The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.

Authors:  I Panagopoulos; N Pandis; S Thelin; C Petersson; F Mertens; A Borg; U Kristoffersson; F Mitelman; P Aman
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

7.  The FHIT gene at 3p14.2 is abnormal in breast carcinomas.

Authors:  M Negrini; C Monaco; I Vorechovsky; M Ohta; T Druck; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

8.  Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases.

Authors:  S Hayashi; K Tanimoto; K Hajiro-Nakanishi; E Tsuchiya; M Kurosumi; Y Higashi; K Imai; K Suga; K Nakachi
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

9.  Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.

Authors:  K Yanagisawa; M Kondo; H Osada; K Uchida; K Takagi; A Masuda; T Takahashi; T Takahashi
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

10.  Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.

Authors:  F Numa; K Hirabayashi; N Tsunaga; H Kato; K O'Rourke; H Shao; C Stechmann-Lebakken; J Varani; A Rapraeger; V M Dixit
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

View more
  5 in total

1.  Loss of fragile histidine triad protein expression in inflammatory bowel disease.

Authors:  Chun-Mei Xu; Chuan-Hu Qiao
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

2.  Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.

Authors:  Elangovan Thavathiru; John H Ludes-Meyers; Michael C MacLeod; C Marcelo Aldaz
Journal:  Mol Carcinog       Date:  2005-11       Impact factor: 4.784

3.  FHIT gene expression is repressed by mitogenic signaling through the PI3K/AKT/FOXO pathway.

Authors:  Kevin Kelley; Steven J Berberich
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

4.  Identification of ligands and coligands for the ecdysone-regulated gene switch.

Authors:  E Saez; M C Nelson; B Eshelman; E Banayo; A Koder; G J Cho; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

5.  Impaired FHIT expression characterizes serous ovarian carcinoma.

Authors:  K Ozaki; T Enomoto; K Yoshino; M Fujita; G S Buzard; K Kawano; M Yamasaki; Y Murata
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.